Liposome-Mediated Natural Compounds in Cancer Therapy
A special issue of Future Pharmacology (ISSN 2673-9879).
Deadline for manuscript submissions: closed (30 April 2025) | Viewed by 268
Special Issue Editors
Interests: phytochemicals; natural products; cancer; chemotherapy; chemoprotection; liposomes
Interests: liposomes; nanoparticles; hydrogels; 2D nanomaterials; biopolymers
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer remains one of the leading causes of death worldwide. Chemotherapy is associated with poor selectivity, systemic toxicity, and drug resistance. In recent years, there has been growing interest in exploiting the potential of natural compounds derived from plants, fungi, and other sources for cancer therapy. These bioactive compounds often exhibit remarkable anti-cancer properties, including the ability to inhibit tumor growth and induce apoptosis. However, challenges related to their low bioavailability, instability, and non-specific distribution have hindered their widespread clinical application.
Liposome-based drug delivery systems are a promising solution to these challenges as they offer increased biocompatibility, improved solubility for poorly water-soluble compounds, and the potential for targeted delivery to tumor sites. By encapsulating natural compounds in liposomes, it is possible to enhance their stability, bioavailability, and therapeutic efficacy, while reducing their systemic toxicity and side effects. This Special Issue aims to provide a comprehensive overview of the latest advancements in the liposome-dependent delivery of natural compounds, both alone and in combination with chemotherapeutic agents, for cancer therapy.
This Special Issue welcomes original research articles and reviews. Their research areas may include (but are not limited to) the following:
- The design and optimization of liposomal formulations for the delivery of natural products;
- Strategies for achieving the targeted delivery of natural products to cancer cells;
- The use of liposomes for delivering combination therapies that include natural compounds and chemotherapeutics.
We look forward to receiving your contributions.
Dr. Panayiota Christodoulou
Dr. Athanasios Skouras
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Future Pharmacology is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- liposomes
- nanocarriers
- cancer
- drug delivery
- natural compounds
- chemotherapy-induced cytotoxicity
- chemoprevention
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
